<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100701">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01749059</url>
  </required_header>
  <id_info>
    <org_study_id>PDX-003-11</org_study_id>
    <nct_id>NCT01749059</nct_id>
  </id_info>
  <brief_title>The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease</brief_title>
  <acronym>CCHD</acronym>
  <official_title>The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pediatrix Medical Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pediatrix Medical Group</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the impact of implementing a universal pulse
      oximeter screening as a way to detect critical congenital heart disease in otherwise
      well-appearing newborns.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>True Positive Rate</measure>
    <time_frame>One year follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>The numbers of subjects who have a positive pulse oximetry screening test and who in follow-up evaluation are found to have CCHD.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>False Positive Rate</measure>
    <time_frame>One year follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>The numbers of subjects who have a positive pulse oximetry screening test and who in follow-up evaluation are found to have normal hearts.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>True Negative Rate</measure>
    <time_frame>One year follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of subjects who have a negative pulse oximetry screening test and who in follow-up evaluation are found to have normal hearts.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>False Negative Rate</measure>
    <time_frame>One year follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of subjects who have a negative pulse oximetry screening test and who in follow-up evaluation are found to have heart defects.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Congenital Heart Defect</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Neonates known to have a congenital heart defect at the time of screening.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Documentation of informed consent and authorization.

          2. Full term and late preterm newborns (EGA 35-44 weeks)

          3. On room air

          4. Neonates known to have a congenital heart defect at the time of screening, e.g.,
             antenatal diagnosis or diagnosis within the first 24 hours after birth

          5. Parents agree to follow-up contact post discharge

        Exclusion Criteria:

          1. On supplemental oxygen

          2. Admitted to the Neonatal Intensive Care Unit

          3. Parents do not agree to follow-up

          4. Greater than 30 days of age
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reese H Clark, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatrix Medical Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Kelleher, MSHS</last_name>
    <phone>800-243-3839</phone>
    <phone_ext>5026</phone_ext>
    <email>amy_kelleher@pediatrix.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Capital Health Regional Medical Center - Pediatrix Medical Group</name>
      <address>
        <city>Trenton</city>
        <state>New Jersey</state>
        <zip>08638</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen T Moffitt, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Stephen T Moffitt, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 6, 2014</lastchanged_date>
  <firstreceived_date>December 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
